{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T04:15:02Z","timestamp":1792124102855,"version":"4.4.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["10070012010003"],"award-info":[{"award-number":["10070012010003"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","award":["2020-1\/12960"],"award-info":[{"award-number":["2020-1\/12960"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.radonc.2022.11.008","type":"journal-article","created":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T16:07:26Z","timestamp":1669046846000},"page":"214-221","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Development of a consensus-based delineation guideline for locally recurrent rectal cancer"],"prefix":"10.1016","volume":"177","author":[{"given":"Floor","family":"Piqeur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britt J.P.","family":"Hupkens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefi","family":"Nordkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marnix G.","family":"Witte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Meijnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heleen M.","family":"Ceha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maaike","family":"Berbee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margriet","family":"Dieters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Heyman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Valdman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin P.","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost","family":"Nederend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harm J.T.","family":"Rutten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacobus W.A.","family":"Burger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corrie A.M.","family":"Marijnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heike M.U.","family":"Peulen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2022.11.008_b0005","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1503\/cjs.025911","article-title":"Intentionally curative treatment of locally recurrent rectal cancer: a systematic review","volume":"56","author":"Tanis","year":"2013","journal-title":"Can J Surg"},{"key":"10.1016\/j.radonc.2022.11.008_b0010","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/DCR.0000000000000547","article-title":"Treatment of locally recurrent rectal carcinoma in previously (chemo)irradiated patients: a review","volume":"59","author":"Van Der Meij","year":"2016","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.radonc.2022.11.008_b0015","doi-asserted-by":"crossref","first-page":"3958","DOI":"10.1200\/JCO.2004.01.023","article-title":"Clinical nature and prognosis of locally recurrent rectal cancer after total mesorectal excision with or without preoperative radiotherapy","volume":"22","author":"van den Brink","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2022.11.008_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2019.10.037","article-title":"Locally recurrent rectal cancer; long-term outcome of curative surgical and non-surgical treatment of 447 consecutive patients in a tertiary referral centre","volume":"46","author":"Hagemans","year":"2020","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.radonc.2022.11.008_b0025","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1245\/s10434-014-4317-y","article-title":"Early and late outcomes of surgery for locally recurrent rectal cancer: a prospective 10-year study in the total mesorectal excision era","volume":"22","author":"Nielsen","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.radonc.2022.11.008_b0030","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1463-1318.2005.00877.x","article-title":"Surgery and pre-operative irradiation for locally advanced or recurrent rectal cancer in patients over 75 years of age","volume":"8","author":"Larsen","year":"2006","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.radonc.2022.11.008_b0035","doi-asserted-by":"crossref","unstructured":"van Gijn W, M Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncology. 2011;12:575-582. doi:10.1016\/S1470.","DOI":"10.1016\/S1470-2045(11)70097-3"},{"key":"10.1016\/j.radonc.2022.11.008_b0040","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.clon.2017.11.009","article-title":"External beam re-irradiation in rectal cancer","volume":"30","author":"Owens","year":"2018","journal-title":"Clin Oncol"},{"key":"10.1016\/j.radonc.2022.11.008_b0045","doi-asserted-by":"crossref","unstructured":"Sun DS, Zhang JD, Li L, Dai Y, Yu JM, Shao ZY. Accelerated hyperfractionation field-involved re-irradiation combined with concurrent capecitabine chemotherapy for locally recurrent and irresectable rectal cancer. British Journal of Radiology. 2012;85:259-264. doi:10.1259\/bjr\/28173562.","DOI":"10.1259\/bjr\/28173562"},{"key":"10.1016\/j.radonc.2022.11.008_b0050","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.radonc.2019.05.021","article-title":"Practical effectiveness of re-irradiation with or without surgery for locoregional recurrence of rectal cancer: a meta-analysis and systematic review","volume":"140","author":"Lee","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2022.11.008_b0055","doi-asserted-by":"crossref","DOI":"10.1080\/0284186X.2020.1725111","article-title":"Re-irradiation for recurrent rectal cancer\u2013a single-center experience","volume":"59","author":"Al-Haidari","year":"2020","journal-title":"Acta Oncol (Madr)"},{"key":"10.1016\/j.radonc.2022.11.008_b0060","doi-asserted-by":"crossref","DOI":"10.1245\/s10434-016-5250-z","article-title":"The use of re-irradiation in locally recurrent, non-metastatic rectal cancer","volume":"23","author":"Susko","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.radonc.2022.11.008_b0065","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.radonc.2014.11.021","article-title":"Reirradiation of locally recurrent rectal cancer: a systematic review","volume":"113","author":"Guren","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2022.11.008_b0070","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.adro.2016.02.002","article-title":"Efficacy and toxicity of rectal cancer reirradiation using IMRT for patients who have received prior pelvic radiation therapy","volume":"1","author":"Youssef","year":"2016","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.radonc.2022.11.008_b0075","doi-asserted-by":"crossref","unstructured":"Beyond TME Collaborative. Consensus statement on the multidisciplinary management of patients with recurrent and primary rectal cancer beyond total mesorectal excision planes. In: The British Journal of Surgery. Vol 100. ; 2013. doi:10.1002\/bjs.9192.","DOI":"10.1002\/bjs.9192"},{"key":"10.1016\/j.radonc.2022.11.008_b0080","first-page":"28","article-title":"Rectal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","author":"Glynne-Jones","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.radonc.2022.11.008_b0085","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.ijrobp.2005.09.017","article-title":"Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: a multicentric phase II study","volume":"64","author":"Valentini","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.11.008_b0090","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1002\/bjs.9569","article-title":"Feasibility of reirradiation in the treatment of locally recurrent rectal cancer","volume":"101","author":"Bosman","year":"2014","journal-title":"Br J Surg"},{"key":"10.1016\/j.radonc.2022.11.008_b0095","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1016\/j.ejso.2020.11.204","article-title":"Induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as neoadjuvant treatment for locally recurrent rectal cancer: the PelvEx II study","volume":"47","author":"Voogt","year":"2021","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.radonc.2022.11.008_b0100","doi-asserted-by":"crossref","first-page":"e213","DOI":"10.1093\/bjs\/znab065","article-title":"Curative treatment of locally recurrent rectal cancer: is induction chemotherapy warranted?","volume":"108","author":"Voogt","year":"2021","journal-title":"Br J Surg"},{"key":"10.1016\/j.radonc.2022.11.008_b0105","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.3748\/wjg.v17.i13.1674","article-title":"Patterns of local recurrence in rectal cancer after a multidisciplinary approach","volume":"17","author":"Enr\u00edquez-Navascu\u00e9s","year":"2011","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.radonc.2022.11.008_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2011.08.011","article-title":"Target volume delineation variation in radiotherapy for early stage rectal cancer in the Netherlands","volume":"102","author":"Nijkamp","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2022.11.008_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2009.11.012","article-title":"Prospective randomized double-blind pilot study of site-specific consensus atlas implementation for rectal cancer target volume delineation in the cooperative group setting","volume":"79","author":"Fuller","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.11.008_b0120","doi-asserted-by":"crossref","DOI":"10.1093\/bjs\/znab065","article-title":"Curative treatment of locally recurrent rectal cancer: is induction chemotherapy warranted?","volume":"108","author":"Voogt","year":"2021","journal-title":"Br J Surg"},{"key":"10.1016\/j.radonc.2022.11.008_b0125","doi-asserted-by":"crossref","DOI":"10.1002\/jso.23457","article-title":"Management of recurrent rectal cancer: practical insights in planning and surgical intervention","volume":"109","author":"Yeo","year":"2014","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.radonc.2022.11.008_b0130","first-page":"160","article-title":"Metrics to evaluate the performance of auto-segmentation for radiation treatment planning: a critical review","author":"Sherer","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2022.11.008_b0135","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.radonc.2016.07.017","article-title":"International consensus guidelines on clinical target volume delineation in rectal cancer","volume":"120","author":"Valentini","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2022.11.008_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2020.11.204","article-title":"Induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as neoadjuvant treatment for locally recurrent rectal cancer: the PelvEx II study","volume":"47","author":"Voogt","year":"2021","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.radonc.2022.11.008_b0145","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1007\/s00261-019-02003-5","article-title":"Locally recurrent rectal cancer: what the radiologist should know","volume":"44","author":"Ganeshan","year":"2019","journal-title":"Abdom Radiol"},{"key":"10.1016\/j.radonc.2022.11.008_b0150","doi-asserted-by":"crossref","unstructured":"Messiou C, Chalmers AG, Boyle K, Wilson D, Sagar P. Pre-operative MR assessment of recurrent rectal cancer. British Journal of Radiology. 2008;81. doi:10.1259\/bjr\/53300246.","DOI":"10.1259\/bjr\/53300246"},{"key":"10.1016\/j.radonc.2022.11.008_b0155","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.10090725","article-title":"Absence of tumor invasion into pelvic structures in locally recurrent rectal cancer: Prediction with preoperative MR imaging","volume":"256","author":"Dresen","year":"2010","journal-title":"Radiology"},{"key":"10.1016\/j.radonc.2022.11.008_b0160","article-title":"Validation of MRI and surgical decision making to predict a complete resection in pelvic exenteration for recurrent rectal cancer","volume":"Vol 60","author":"Brown","year":"2017","journal-title":"In: Dis Colon Rectum"},{"key":"10.1016\/j.radonc.2022.11.008_b0165","doi-asserted-by":"crossref","DOI":"10.1007\/s00330-010-2052-8","article-title":"Value of MRI and diffusion-weighted MRI for the diagnosis of locally recurrent rectal cancer","volume":"21","author":"Lambregts","year":"2011","journal-title":"Eur Radiol"},{"key":"10.1016\/j.radonc.2022.11.008_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2015.05.019","article-title":"Remaining cancer cells within the fibrosis after neo-adjuvant treatment for locally advanced rectal cancer","volume":"41","author":"Tanaka","year":"2015","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.radonc.2022.11.008_b0175","doi-asserted-by":"crossref","DOI":"10.1093\/bjs\/znac083","article-title":"Locally recurrent rectal cancer: oncological outcomes with different treatment strategies in two tertiary referral units","volume":"109","author":"Nordkamp","year":"2022","journal-title":"Br J Surg"},{"key":"10.1016\/j.radonc.2022.11.008_b0180","first-page":"11","article-title":"Effect of pelvic bone marrow sparing intensity modulated radiation therapy on acute hematologic toxicity in rectal cancer patients undergoing chemo-radiotherapy","author":"Huang","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2022.11.008_b0185","doi-asserted-by":"crossref","DOI":"10.1007\/s11547-015-0605-2","article-title":"A prospective phase II study of magnetic resonance imaging guided hematopoietical bone marrow\u2013sparing intensity\u2013modulated radiotherapy with concurrent chemotherapy for rectal cancer","volume":"121","author":"Jianyang","year":"2016","journal-title":"Radiol Med (Torino)"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814022045522?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814022045522?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T03:29:55Z","timestamp":1778729395000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814022045522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":37,"alternative-id":["S0167814022045522"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2022.11.008","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a consensus-based delineation guideline for locally recurrent rectal cancer","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2022.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}